Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Effectiveness of Hepatitis B Virus Vaccination Program in Egypt: Seroprotection and HBV infection

Domain:

healthcare
Creator:
Sai
Publisher:
unp
Host:avatar

Visit

doi.orgwww.researchgate.net

Similar

Effect of Hepatitis B Virus (HBV) Infection on Lipid Profile in Ghanaian PatientsHepatitis B Virus (HBV) Risk Assessment — GhanaCirculation of hepatitis delta virus and occult hepatitis B virus infection amongst HIV/HBV co-infected patients in Korle-Bu, GhanaModelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South AfricaA study of knowledge, experience and beliefs about hepatitis B virus (HBV) infection in south western UgandaScreening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

Effect of Hepatitis B Virus (HBV) Infection on Lipid Profile in Ghanaian Patients

Background: Worldwide, approximately 257 million people have chronic hepatitis B virus (HBV) infec

Hepatitis B Virus (HBV) Risk Assessment — Ghana

A comprehensive R-based analysis pipeline and additional files for the manuscript "A CROSS-SECTIONAL

Circulation of hepatitis delta virus and occult hepatitis B virus infection amongst HIV/HBV co-infected patients in Korle-Bu, Ghana

Background Within HIV/HBV infected patients, an increase in HDV infection has been observed; there

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa

Background: International sustainable development goals for the elimination of viral hepatitis a

A study of knowledge, experience and beliefs about hepatitis B virus (HBV) infection in south western Uganda

ABSTRACT Introduction United Nations susta

Screening, characterisation and prevention of Hepatitis B virus (HBV) co-infection in HIV-positive children in South Africa

Background
In South Africa, the first HBV vaccine dose is administered at age 6 weeks, leaving